---
title: "AllianceBernstein | 8-K: FY2026 Q1 Revenue: USD 1.202 B"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284353076.md"
datetime: "2026-04-28T10:31:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284353076.md)
  - [en](https://longbridge.com/en/news/284353076.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284353076.md)
---

# AllianceBernstein | 8-K: FY2026 Q1 Revenue: USD 1.202 B

Revenue: As of FY2026 Q1, the actual value is USD 1.202 B.

EPS: As of FY2026 Q1, the actual value is USD 0.92, beating the estimate of USD 0.76.

EBIT: As of FY2026 Q1, the actual value is USD 334.01 M.

The provided reference document, a Form 8-K filing by AllianceBernstein Holding L.P., indicates that AllianceBernstein L.P. and AllianceBernstein Holding L.P. issued a news release on April 28, 2026, announcing their financial and operating results for the quarter ended March 31, 2026 . However, the actual financial and operational metrics, such as segment revenue, net income, gross margin, operating profit, operating costs, cash flow, free cash flow, or any specific company-specific indicators, are not detailed within the provided text . Additionally, no outlook or guidance content is present in this filing .

### Related Stocks

- [AB.US](https://longbridge.com/en/quote/AB.US.md)

## Related News & Research

- [AllianceBernstein Holding L.P. 1Q 2026: Net income $85.2M, EPS $0.92— 10-Q Summary](https://longbridge.com/en/news/284937601.md)
- [Yext to Announce First Quarter Fiscal Year 2027 Financial Results on June 2, 2026 | YEXT Stock News](https://longbridge.com/en/news/286970613.md)
- [West Pharma amends 8-K on material cyberattack disclosure](https://longbridge.com/en/news/287111623.md)
- [LOWE'S REPORTS FIRST QUARTER 2026 SALES AND EARNINGS RESULTS | LOW Stock News](https://longbridge.com/en/news/287043063.md)
- [Dear Future SpaceX (SPCX) Stock Fans, Mark Your Calendars for June 12](https://longbridge.com/en/news/286809659.md)